SOLUTIONS
The First Bio-Fabless Diagnostics Company
A Next-Generation
Biochip Platform
Delivering rapid, accurate, and accessible clinical testing through
semiconductor innovation.
Biochip + Devices
End-to-End Solutions Built on Intellectual Property
Sample In, Data Out
The Novascope system combines disposable semiconductor biochips (cartridges), a compact reader and devices designed and engineered for a wide range of clinical and care environments.
Each cartridge consists of proprietary bioprobe coatings, and BioFET sensors capable of femtogram-level detection. The reader provides automated signal processing and data analytics, delivering quantitative results with minimal operator intervention.
The result is laboratory-grade performance in scalable, user-friendly hardware.
From Chip to Data: Novascope’s End-To-End Solution
A Walled Garden for Seamless and Vertical Integration
We are building a vertically integrated BioIC ecosystem, from bioprobes, disposable biochips, test result readers to diagnostic devices. From chip architecture and surface chemistry to assay development, firmware, analytics, and clinical validation, every layer of our technology stack is designed to work seamlessly together.
This end-to-end integration allows us to control performance, quality, and user experience in the same way category-defining companies have done in other technology industries.
Novascope NVDFlow™ Automated BioChip Platform System
High-Precision, High Throughput and Sample-to-Answer for Blood Biomarkers Analysis
Clinical & Care Settings
Democratization of Medical Diagnostics
In-vitro diagnostics anytime and anywhere
We aim to provide a family of IVD instruments with different levels of automation and throughput to be deployed across the full spectrum of clinical and care settings.
Compact, manual or semi-automated devices are suitable for home care environments and small clinics, enabling decentralized testing where patients first interact with the healthcare system. At the same time, larger fully automated instruments are designed for hospitals and large medical centers, where higher throughput, integrated workflow management, and laboratory automation are required. Because all instruments utilize the same underlying biochip architecture, healthcare providers can access consistent analytical performance across settings.
Detection of Ultra-Low-Abundance Biomarkers
Our highly sensitive proprietary biochip coated with highly specific bioprobes can detect key biomarkers circulate in the peripheral blood at extremely low concentrations and hence identify neurodegenerative diseases before symptoms appear. Our platform enables earlier, earlier and more accessible screening compared to traditional diagnostic modalities such as cerebrospinal fluid testing (CSF) or advanced neuroimaging such as PET.
Request Investor Deck : ir@novascopedx.com
Novascope is a semiconductor-driven biotech company developing ultra-sensitive biochips for rapid, early disease detection and precision diagnostics
© 2026 Novascope Diagnostics Inc.